At What Age Should I Start Seriously Tracking My Biomarkers of Aging?

The big picture

What are the biomarkers of aging you should be tracking?

The biomarkers of aging you should be tracking measure your metabolism, your hormones, your inflammation levels, and even the chemical tags on your DNA, the systems that drift slowly as you age. The biomarkers of aging are the specific, testable signals that reveal how quickly those systems are drifting, sometimes well before you notice a symptom.

Tracking them matters because chronological age (the number of birthdays you've had) tells you relatively little about your actual risk. Two people who are both 50 can have bodies that function years apart. The right biomarkers help turn that invisible difference into data you can act on.

At Protocol Health in Scarsdale, NY, we treat these numbers as the starting point for individualized, physician-led care — not as a scoreboard. This guide walks through the markers worth knowing, what they may indicate, and how they fit into a longevity plan, in person in Scarsdale or by telehealth in NY, NJ, CT, FL and CA.

Quick answer

The short list of what to track

The short list of what to track covers a few groups of biomarkers of aging: biological age (via epigenetic DNA-methylation testing), metabolic markers (fasting glucose, HbA1c, fasting insulin, lipid particles), inflammation (hs-CRP), hormones (testosterone, estradiol, thyroid, DHEA), and body composition (lean mass, visceral fat, bone density).

Layered on top, advanced screening tools, like a multi-cancer blood test or whole-body imaging, may help surface age-related disease earlier, though neither is part of standard US screening guidelines. No single number defines your aging; the pattern across several is more informative.

The practical move is to establish a baseline, then re-test over time to see the trend. A physician can interpret how these markers interact and translate them into changes that fit your health, history, and goals.

By decade

At what age should I start seriously tracking my biomarkers?

Start seriously tracking your biomarkers in your 30s, after a simple baseline in your 20s, which is earlier than most people do and done in layers. No guideline names a single age for biomarker tracking, but the major screening guidelines set useful anchors, and Protocol Health builds on them rather than replacing them.

In your 20s, the goal is a baseline. The 2018 AHA/ACC cholesterol guideline says that in young adults aged 20 to 39, an assessment of lifetime cardiovascular risk helps the clinician and patient talk about risk and puts the emphasis on intensive lifestyle efforts. In practice that means knowing your blood pressure, a lipid panel and a fasting glucose or HbA1c, then not ignoring them for a decade.

In your 30s, tracking becomes serious. This is the decade when metabolic drift usually starts quietly, before anything feels wrong. The US Preventive Services Task Force recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 who have overweight or obesity. For many people the 30s are the right time to add fasting insulin, ApoB, hs-CRP, a hormone panel and a body composition scan, and to repeat them on a schedule so you can see a trend.

From 40, the panel widens. The same cholesterol guideline moves adults aged 40 to 75 to formal 10-year cardiovascular risk scoring to guide decisions such as statin therapy. This is also when hormone shifts (perimenopause, declining testosterone), bone density and cancer screening schedules enter the conversation. From 50 onward, advanced screening such as multi-cancer blood tests or imaging may be worth discussing for the right person.

Start sooner if you have a strong family history of early heart disease, diabetes or cancer, or if symptoms like fatigue, weight change or poor recovery are already present. A Protocol Health clinician can set your starting age and panel from your history rather than from a generic chart.

The core concept

Biological age vs. chronological age: what's the difference?

Chronological age is simply how long you've been alive. Biological age is an estimate of how old your body appears to function, based on cellular and molecular measurements. When your biological age runs lower than your chronological age, it may suggest your systems are aging more slowly — and vice versa.

One of the most studied ways to estimate biological age is epigenetic testing, which reads DNA-methylation patterns — chemical marks that accumulate on your genes over time. Research suggests these 'epigenetic clocks' correlate with health and longevity outcomes at a population level, though they are best used as a trend to track rather than a single verdict.

A biological age test like the TruAge test can give you a concrete baseline. Re-testing after months of targeted lifestyle and medical changes may help you and your provider see whether the direction of travel is moving favorably.

Under the hood

How do epigenetic clocks estimate biological age?

Epigenetic clocks estimate biological age from DNA methylation, the chemical tags that switch genes on and off and drift in predictable ways as we age. The first generation of clocks was trained to predict chronological age, which made them accurate at guessing birthdays and less useful for predicting health.

Newer clocks were trained on health outcomes instead. DNAm PhenoAge, published in Aging in 2018, was built from composite clinical measures of phenotypic age and outperformed earlier epigenetic measures at predicting all-cause mortality, cancers, healthspan, physical functioning and Alzheimer's disease. Higher epigenetic age relative to chronological age was associated with more activation of pro-inflammatory pathways. That is the scientific basis for treating a biological age test as a risk signal rather than a party trick.

Two cautions apply. These clocks were validated on populations, so an individual result carries measurement noise, and different commercial tests use different clocks that do not always agree. Use one test consistently, re-test at sensible intervals, and read the trend with a clinician.

The essentials

Which blood biomarkers reveal how you're aging?

The blood biomarkers that reveal how you're aging fall into three groups: metabolic markers, inflammation and hormones. Metabolic health is often the first system to drift. Fasting glucose and HbA1c reflect longer-term blood sugar, while fasting insulin can flag insulin resistance before glucose rises. An advanced lipid panel (including particle number and ApoB) can offer a sharper cardiovascular picture than standard cholesterol alone.

Inflammation is a second pillar. High-sensitivity C-reactive protein (hs-CRP) is a widely used marker of chronic, low-grade inflammation, which research links to many age-related conditions. Following it over time can be informative when interpreted alongside the rest of your panel.

Hormones round out the picture. Testosterone, estradiol, thyroid markers, and DHEA all shift with age and can influence energy, body composition, mood, and metabolism. For a deeper hormonal read, a DUTCH hormone panel maps not just levels but how your body metabolizes hormones — data that helps a clinician assess whether options like male or female hormone optimization may be appropriate for you.

Beyond the blood draw

Body composition and structural markers

Body composition and structural markers matter because what you weigh matters far less than what you're made of. Two people at the same weight can carry very different amounts of muscle, visceral fat, and bone — and those differences can shape very different aging trajectories. Lean muscle mass, in particular, is increasingly viewed as supportive of metabolic health and healthy aging.

A precise body composition scan breaks weight down into lean mass, fat mass, and water distribution, and can help track visceral fat (the metabolically active fat around your organs) over time. That data is far more actionable than a bathroom scale.

Structural screening can add another layer. Advanced imaging such as a full-body MRI and early-detection tools like Galleri multi-cancer screening are designed to help surface age-related concerns earlier, when there may be more options. These are screening tools used under physician guidance, not standalone diagnoses, and neither is part of standard US screening guidelines.

Safety markers

Which basic biomarkers do longevity panels skip?

The basic biomarkers longevity panels often skip, such as blood pressure, kidney function and a complete blood count, are some of the most useful and least glamorous. Blood pressure is cheap, repeatable and strongly tied to heart, kidney and brain health, and it is often missing from boutique longevity panels that focus on novel markers.

Kidney function (creatinine with eGFR, and urine albumin), liver enzymes and a complete blood count are safety markers. They catch problems that change how other results should be read, and they matter even more for anyone on hormone therapy, GLP-1 medication or supplements. Hematocrit, for example, is a standard monitoring check for men on testosterone therapy.

Protocol Health includes these basics in a longevity work-up before adding advanced tests. A biological age result means little if an untreated blood pressure problem is sitting underneath it.

Physical function

Grip strength and fitness: the biomarkers a blood test misses

Grip strength and fitness are the biomarkers a blood test misses, and physical function is one of the strongest aging signals available. In the PURE study, published in The Lancet, grip strength was measured in 139,691 adults across 17 countries and followed for a median of four years. Every 5 kg lower grip strength was associated with a 16% higher risk of death from any cause, and grip strength predicted all-cause and cardiovascular death more strongly than systolic blood pressure.

Cardiorespiratory fitness is the other heavyweight. A cohort of 122,007 patients who underwent treadmill testing at a US academic center found that all-cause mortality fell steadily as fitness rose, with no observed upper limit of benefit. The gap in risk between the least fit and the most fit was comparable to or larger than that for traditional risk factors such as smoking and diabetes. These are observational associations, not proof that training changes your clock, but they explain why longevity medicine measures strength and fitness alongside labs.

Practical tracking means a grip-strength reading, a fitness estimate such as VO2 max or a timed walk test, and lean mass from a body composition scan, repeated over time. At Protocol Health these sit next to your blood biomarkers in a single picture.

Re-testing

How often should you re-test biomarkers of aging?

Re-testing is where biomarker tracking earns its value, because a single result cannot show direction. A sensible default for most adults is a comprehensive panel once a year, with blood pressure checked more often if it runs high.

When you change something deliberately, such as starting hormone therapy, a GLP-1 medication, a new training block or a major diet change, the relevant markers are usually re-checked sooner, often after about three months, so you and your clinician can see the effect. Slow-moving measures behave differently: body composition shifts over months, and biological age tests are generally most informative when repeated no more than once or twice a year with the same test.

Consistency matters as much as frequency. Draw labs at the same time of day, in the same fasting state and at the same lab where possible, so the trend reflects your biology rather than the conditions of the draw. Protocol Health schedules re-testing as part of your plan, so the numbers arrive with someone ready to interpret them.

Candidacy

Who should be tracking biomarkers of aging?

Anyone who wants to catch drift early should consider tracking biomarkers of aging, and you don't need to be sick to benefit. Many people begin biomarker tracking in their 30s and 40s specifically because everything still feels fine — often an ideal window to establish a baseline and notice subtle drift early.

It's especially worth considering if you have a family history of heart disease, diabetes, or cancer; if you're noticing changes in energy, sleep, body composition, or recovery; or if you simply want to make health decisions from data rather than guesswork. Those pursuing longevity and preventive health tend to value the trend line as much as any single result.

Because the right panel depends on your history, goals, and risk factors, biomarker testing is most useful when a clinician helps you choose what to measure — and, just as importantly, what not to. Not every test is right for every person.

Honest context

Are these tests reliable, and what are the limits?

These tests are most reliable as a trend, and their main limit is that biomarkers are indicators, not crystal balls. Biological-age estimates can vary between testing methods and can shift with day-to-day factors, which is why the trend over repeated tests is more meaningful than any single snapshot. No test can predict your lifespan or guarantee an outcome.

Screening tools carry trade-offs worth understanding. Broad imaging and multi-cancer blood tests can surface incidental findings that require follow-up, and no screen catches everything. This is precisely why physician interpretation matters — context helps guard against both false alarm and false reassurance.

The goal isn't to chase perfect numbers or collect every test available. It's to gather enough of the right information, interpreted well, to make informed decisions with a qualified provider. This article is educational and not a substitute for personalized medical advice.

How we work

The Protocol Health approach to tracking your aging

At Protocol Health, biomarker tracking isn't a menu of à la carte tests — it's a physician-led process. Our Signature Health & Longevity Assessment brings the pieces together: a biological-age baseline, comprehensive labs, body composition, and a real clinical conversation about what the results may mean for you.

We're a family-owned, physician-led clinic in Scarsdale, seeing patients in person at the clinic and by telehealth in NY, NJ, CT, FL and CA. That means your numbers are read by a real clinical team who knows your history — not returned as a raw report you're left to decode alone.

From there, we build an individualized plan and re-test to track progress over time. If you're ready to see where your biology stands today, a TruAge biological age test is a clear place to start — or take our quiz to find the right starting point for your goals.

To answer the question this guide started with: get a baseline in your 20s, start serious, trended tracking in your 30s, and widen the panel from about 40, sooner with a strong family history. The trend across repeated tests matters more than any single result.

FAQ

Frequently Asked Questions

Explore

Related at Protocol Health

• TruAge biological age test →
• Signature Health & Longevity Assessment →
• Galleri multi-cancer screening →
• Longevity & preventive health →